A survey of infectious disease clinical practices among pediatric blood and marrow transplant programs in the United States
Pediatric Blood & Cancer2015Vol. 62(4), pp. 731–735
Citations Over Time
Abstract
We assessed clinical practice standards for infectious complications among pediatric blood and marrow transplant (PBMT) recipients. An anonymous online survey was sent to all 64 pediatric program directors (PD) of PBMT centers in the United States, which are accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). The overall response rate was 56% (CI: 44-68%); variations in clinical practices were noted regarding (i) surveillance for late onset cytomegalovirus (CMV) infection and (ii) pharmacokinetic/therapeutic drug monitoring of antimicrobials. Prospective studies among PBMT recipients to address infectious complications among this population and variations in clinical practice may be required.
Related Papers
- → 023 HIV-infected status is associated with increased recurrence of acute coronary syndrome. Results of long term follow up of the PACS-HIV study(2012)1 cited
- → Proposals on Severe Acute Respiratory Syndrome's and Other New Infectious Diseases' Clinical Prevention Practices(2006)
- → Ward Round - Non-resolving pleural effusion in a patient with HIV infection(2010)
- → Management of pregnant women with congenital cytomegalovirus and parvovirus infection(2021)